ArticleHeadache2026

Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open-label ASCEND acute migraine study.

Jessica Ailani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.